• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. XIENCE SKYPOINT¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. XIENCE SKYPOINT¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 1804350-18
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Dyspnea (1816); Hypersensitivity/Allergic reaction (1907); Dizziness (2194)
Date of Event 12/25/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the procedure was to treat a lesion in the left anterior descending (lad) coronary artery.The 3.5x18 mm xience skypoint stent was implanted on (b)(6) 2024 and on (b)(6) 2024 the patient experienced minor sinus pressure, heaviness in the chest with slight difficulty in breathing, hoarse or strained voice, clear post nasal drip, and dizziness or light headed feeling.The patient was discharged without further treatment and was instructed to wait an additional 7 days for symptoms to resolve.The patient was taking brilinta, and rosuvastatin 10 mg.The brilinta gave him a rash and they stopped the medication on (b)(6) 2025, and was switched to plavix on (b)(6) 2025.Rosuvastatin was increased from 10 mg to 20 mg.The patient went to urgent care around (b)(6) 2025 and they diagnosed him with sinusitis and prescribed claritin and a nasal spray.The patient is concerned about an allergic reaction.They have an appointment with their cardiologist in 4 weeks and plan to see an allergist.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot the reported patient effects of dizziness and hypersensitivity are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling; therefore, no product-related corrective action will be implemented in this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT¿
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key21210602
Report Number2024168-2025-00769
Device Sequence Number4045684
Product Code NIQ
UDI-Device Identifier08717648233401
UDI-Public(01)08717648233401(17)270812(10)4081541
Combination Product (Y/N)Y
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 01/22/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number1804350-18
Device Catalogue Number1804350-18
Device Lot Number4081541
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/07/2025
Initial Report FDA Received Date01/22/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/13/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age59 YR
Patient SexMale
-
-